Literature DB >> 20113312

Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.

Assia Merabet1, Hellen Houlleberghs, Kate Maclagan, Ester Akanho, Tam T T Bui, Bruno Pagano, Alex F Drake, Franca Fraternali, Penka V Nikolova.   

Abstract

To assess the potential of mutations from the L1 loop of the tumour suppressor p53 as second-site suppressors, the effect of H115N and S116M on the p53 'hot spot' mutations has been investigated using the double-mutant approach. The effects of these two mutants on the p53 hot spots in terms of thermal stability and DNA binding were evaluated. The results show that: (i) the p53 mutants H115N and S116M are thermally more stable than wild-type p53; (ii) H115N but not S116M is capable of rescuing the DNA binding of one of the most frequent p53 mutants in cancer, R248Q, as shown by binding of R248Q/H115N to gadd45 (the promoter of a gene involved in cell-cycle arrest); (iii) the double mutant R248Q/H115N is more stable than wild-type p53; (iv) the effect of H115N as a second-site suppressor to restore DNA-binding activity is specific to R248Q, but not to R248W; (v) molecular-dynamics simulations indicate that R248Q/H115N has a conformation similar to wild-type p53, which is distinct from that of R248Q. These findings could be exploited in designing strategies for cancer therapy to identify molecules that could mimic the effect of H115N in restoring function to oncogenic p53 mutants.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113312     DOI: 10.1042/BJ20091888

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis.

Authors:  Siddharth Singh; Manoj Kumar; Sanjeev Kumar; Shrinka Sen; Pawan Upadhyay; Sayan Bhattacharjee; Naveen M; Vivek Singh Tomar; Siddhartha Roy; Amit Dutt; Tapas K Kundu
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

2.  Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.

Authors:  Sara Calhoun; Valerie Daggett
Journal:  Biochemistry       Date:  2011-05-17       Impact factor: 3.162

3.  Rescue of deleterious mutations by the compensatory Y30F mutation in ketosteroid isomerase.

Authors:  Hyung Jin Cha; Do Soo Jang; Yeon-Gil Kim; Bee Hak Hong; Jae-Sung Woo; Kyong-Tai Kim; Kwan Yong Choi
Journal:  Mol Cells       Date:  2013-06-03       Impact factor: 5.034

4.  A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutation.

Authors:  Adam F Odell; Luke R Odell; Jon M Askham; Hiba Alogheli; Sreenivasan Ponnambalam; Monica Hollstein
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

5.  Structure and stability insights into tumour suppressor p53 evolutionary related proteins.

Authors:  Bruno Pagano; Abdullah Jama; Pierre Martinez; Ester Akanho; Tam T T Bui; Alex F Drake; Franca Fraternali; Penka V Nikolova
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

6.  Variable Mutations at the p53-R273 Oncogenic Hotspot Position Leads to Altered Properties.

Authors:  Ankush Garg; Jagadish Prasad Hazra; Malay Kumar Sannigrahi; Sabyasachi Rakshit; Sharmistha Sinha
Journal:  Biophys J       Date:  2019-12-21       Impact factor: 4.033

7.  Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics.

Authors:  Suryani Lukman; David P Lane; Chandra S Verma
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

8.  Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.

Authors:  T Y Prudnikova; O Villamar-Cruz; S J Rawat; K Q Cai; J Chernoff
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

9.  In silico identification of rescue sites by double force scanning.

Authors:  Matteo Tiberti; Alessandro Pandini; Franca Fraternali; Arianna Fornili
Journal:  Bioinformatics       Date:  2018-01-15       Impact factor: 6.937

10.  Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket.

Authors:  Mohan R Pradhan; Jia Wei Siau; Srinivasaraghavan Kannan; Minh N Nguyen; Zohra Ouaray; Chee Keong Kwoh; David P Lane; Farid Ghadessy; Chandra S Verma
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.